![](/img/cover-not-exists.png)
First report of the safety, tolerability, and pharmacokinetics of the Src kinase inhibitor saracatinib (AZD0530) in Japanese patients with advanced solid tumours
Yasuhito Fujisaka, Yusuke Onozawa, Takayasu Kurata, Hirofumi Yasui, Isao Goto, Kentaro Yamazaki, Nozomu Machida, Junichiro Watanabe, Hitoshi Shimada, Xiaojin Shi, Narikazu BokuVolume:
31
Language:
english
DOI:
10.1007/s10637-012-9809-7
Date:
February, 2013
File:
PDF, 188 KB
english, 2013